Oncolytic Viruses Cancer Therapy. Clinical limitations, safety issues and prospects Oncolytic Viruses Cancer Therapy. Clinical limitations, safety issues and prospects Wild-type viruses with intrinsic oncolytic capacity in human includes DNA viruses like some autonomous parvoviruses and many RNA viruses. Recent advances in molecular biology have allowed the design of several genetically modified viruses, such as adenovirus and herpes simplex virus that specifically replicate in, and kill tumor cells. However, still several hurdles regarding clinical limitations and safety issues should be overcome before this mode of therapy can become of clinical relevance. It includes limited virus spread in tumor masses, stability of virus in the blood, trapping within the liver sinusoids, transendothelial transfer, and/or vector diffusion of viral particles to tumor cells, limited tumor transduction, immune-mediated inactivation or destruction of the virus. An overview is given of the general mechanisms and genetic modifications by which oncolytic viruses achieve tumor cell-specific replication and antitumor efficacy. However, as their therapeutic efficacy in clinical trials is still not optimal, strategies are evaluated that could further enhance the oncolytic potential of conditionally replicating viruses. Книга по Требованию 978-3-6392-0281-6
4376 руб.
Russian
Каталог товаров

Oncolytic Viruses Cancer Therapy. Clinical limitations, safety issues and prospects

  • Автор: Marc Zeicher
  • Мягкий переплет. Крепление скрепкой или клеем
  • Издательство: Книга по Требованию
  • Год выпуска: 2010
  • Кол. страниц: 172
  • ISBN: 978-3-6392-0281-6
Временно отсутствует
?
  • Описание
  • Характеристики
  • Отзывы о товаре
  • Отзывы ReadRate
Wild-type viruses with intrinsic oncolytic capacity in human includes DNA viruses like some autonomous parvoviruses and many RNA viruses. Recent advances in molecular biology have allowed the design of several genetically modified viruses, such as adenovirus and herpes simplex virus that specifically replicate in, and kill tumor cells. However, still several hurdles regarding clinical limitations and safety issues should be overcome before this mode of therapy can become of clinical relevance. It includes limited virus spread in tumor masses, stability of virus in the blood, trapping within the liver sinusoids, transendothelial transfer, and/or vector diffusion of viral particles to tumor cells, limited tumor transduction, immune-mediated inactivation or destruction of the virus. An overview is given of the general mechanisms and genetic modifications by which oncolytic viruses achieve tumor cell-specific replication and antitumor efficacy. However, as their therapeutic efficacy in clinical trials is still not optimal, strategies are evaluated that could further enhance the oncolytic potential of conditionally replicating viruses.
Бумага:   Офсет
Масса:   252 г
Размеры:   148x 210x 9 мм
Отзывы
Найти пункт
 Выбрать станцию:
жирным выделены станции, где есть пункты самовывоза
Выбрать пункт:
Поиск по названию улиц:
Подписка 
Введите Reader's код или e-mail
Периодичность
При каждом поступлении товара
Не чаще 1 раза в неделю
Не чаще 1 раза в месяц
Мы перезвоним

Возникли сложности с дозвоном? Оформите заявку, и в течение часа мы перезвоним Вам сами!

Captcha
Обновить
Сообщение об ошибке

Обрамите звездочками (*) место ошибки или опишите саму ошибку.

Скриншот ошибки:

Введите код:*

Captcha
Обновить